TGFBI and type 1 diabetes mellitus: We further examined the pathological changes in sh-TGFBI-MSC-treated T1DM mice, and histological examination of pancreatic tissues was performed by H&E staining and immunohistochemical staining after sh-TGFBI-MSCs infusion for 30 days.